Axsome Therapeutics

(NASDAQ: AXSM)
Healthcare  |  Biotechnology
20.63 2.39 13.1%
Stock Price | Oct. 15, 2019, 4 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 18.24
52 Week Low: 1.94
52 Week High: 30.5
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Axsome Therapeutics Inc is a United States-based healthcare service provider. As a pre-clinical therapeutics developer, the company attends primarily to central nervous system disorders such as Alzheimer's. Its product portfolio consists of novel drugs like the AXS-02 (disodium zoledronate tetrahydrate), which is an oral, non-opioid therapeutic for chronic pain and the AXS-05, which is a fixed-dose combination of dextromethorphan and bupropion. The AXS-02 addresses pain in over three conditions, such as complex regional pain syndrome, knee osteoarthritis and chronic low back pain. The AXS-05 on the other hand, treats resistant depression and agitation in patients with Alzheimer's disease. Both the products have passed the preclinical, Phase 1 and Phase 2 stages of development.

Read more Read less

Recently Viewed Tickers

Free Stock Watchlist 06/23/2016

3 years ago

Premium Stock Watchlist 06/22/2016

3 years ago